Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
2020
Americas
Europe
Clear all
Type of publications
NITAG documentation
(82)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(65)
Europe
(21)
Africa
(2)
South-East Asia
(1)
Western Pacific
(20)
Countries
Belgium
(1)
Canada
(4)
Chile
(9)
Denmark
(1)
France
(5)
Netherlands
(1)
Sweden
(1)
United Kingdom
(11)
United States of America
(52)
Diseases
COVID-19
(79)
Human papillomavirus (HPV)
(8)
Diphtheria
(1)
Ebola
(3)
Hepatitis A
(1)
Influenza
(9)
Measles
(1)
Meningococcal disease
(1)
Pertussis
(1)
Pneumococcal disease
(3)
Tetanus
(1)
Tuberculosis
(1)
Typhoid
(1)
Varicella
(1)
Yellow fever
(1)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Efficacy/effectiveness
(1)
Target population
Adolescents
(3)
Adults
(3)
Healthcare workers
(5)
Older adults
(2)
Parents/caregivers
(2)
Risk group
(3)
Publication date
2020
(86)
2024
(2)
2023
(27)
2022
(85)
2021
(145)
2019
(18)
2018
(18)
2017
(14)
2016
(18)
2015
(12)
2014
(17)
2013
(6)
2012
(2)
2011
(3)
2010
(7)
2009
(5)
2008
(2)
2007
(4)
86 results found
2020
∙
Steve Anderson
CBER Plans for Monitoring COVID-19 Vaccine Safety and Effectiveness
2020
∙
Tom Shimabukuro, ACIP
CDC post-authorization/post-licensure safety monitoring of COVID-19 vaccines
2020
∙
Sara Oliver, ACIP
Clinical Considerations for Populations Included in Phase 1a
2020
∙
ACIP
Considerations for FDA Licensure vs. Emergency Use Authorization of COVID-19 Vaccines
2020
∙
Sara Oliver, ACIP
Considerations for Populations Included in Phase 1b and 1c
2020
COVID-19 vaccination: BioNTech/Pfizer
2020
∙
ACIP
COVID-19 vaccine implementation
2020
∙
Janell Routh, ACIP
COVID-19 Vaccine Implementation Planning Update
2020
∙
Nancy Messonnier, ACIP
COVID-19 Vaccine Implementation Planning Update
2020
∙
Kathleen Dooling, ACIP
COVID-19 vaccine prioritization: Work Group considerations
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register